| Johanna Engel-brower, MD | |
|
30 E Hickman Rd, Waukee, IA 50263-5011 | |
| (515) 987-3447 | |
| (515) 987-6957 |
| Full Name | Johanna Engel-brower |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 14 Years |
| Location | 30 E Hickman Rd, Waukee, Iowa |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023321585 | NPI | - | NPPES |
| 1023321585 | Medicaid | IA | |
| P01364310 | Other | IA | RR MEDICARE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | R-8921 (Iowa) | Secondary |
| 207Q00000X | Family Medicine | 39668 (Iowa) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Iowa Physicians Clinic Medical Foundation | 8729992318 | 972 |
News Archive
A newly developed method for detecting glucose based on how it absorbs a specific type of light could spell the end of the painful, invasive finger-prick tests diabetics rely on to monitor their condition, says a Texas A&M University biomedical engineer who is developing the technology.
Lakewood-Amedex Inc., a leading developer of novel anti-infective pharmaceuticals, announced today that a recent series of in vitro studies conducted by Southern Research in Birmingham, Alabama, have demonstrated that its novel class of antimicrobials, named bisphosphocins, have proven effective at killing multidrug-resistant (MDR) strains of Mycobacterium tuberculosis, the bacteria responsible for the chronic lung infection tuberculosis.
Tumor-suppressor proteins work to inhibit tumor growth in our bodies and when they win, they spare us a battle with cancer. But one such protein, menin, appears to have a split personality.
Researchers have shown that a peptide (a chain of amino acids) called iRGD helps co-administered drugs penetrate deeply into tumor tissue. The peptide has been shown to substantially increase treatment efficacy against human breast, prostate and pancreatic cancers in mice, achieving the same therapeutic effect as a normal dose with one-third as much of the drug.
As leading organizations representing the Ambulatory Surgery Center (ASC) industry, we wish to address concerns raised in this month's issue of the Journal of the American Medical Association (JAMA) highlighting data from a 2008 Centers for Medicare and Medicaid Services (CMS) pilot study. The industry underscores its strong commitment to patient safety and its nationwide efforts to provide high-quality, patient-centered care at a low cost to the health care system.
› Verified 7 days ago
| Entity Name | Iowa Physicians Clinic Medical Foundation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1366425274 PECOS PAC ID: 8729992318 Enrollment ID: O20031118000363 |
News Archive
A newly developed method for detecting glucose based on how it absorbs a specific type of light could spell the end of the painful, invasive finger-prick tests diabetics rely on to monitor their condition, says a Texas A&M University biomedical engineer who is developing the technology.
Lakewood-Amedex Inc., a leading developer of novel anti-infective pharmaceuticals, announced today that a recent series of in vitro studies conducted by Southern Research in Birmingham, Alabama, have demonstrated that its novel class of antimicrobials, named bisphosphocins, have proven effective at killing multidrug-resistant (MDR) strains of Mycobacterium tuberculosis, the bacteria responsible for the chronic lung infection tuberculosis.
Tumor-suppressor proteins work to inhibit tumor growth in our bodies and when they win, they spare us a battle with cancer. But one such protein, menin, appears to have a split personality.
Researchers have shown that a peptide (a chain of amino acids) called iRGD helps co-administered drugs penetrate deeply into tumor tissue. The peptide has been shown to substantially increase treatment efficacy against human breast, prostate and pancreatic cancers in mice, achieving the same therapeutic effect as a normal dose with one-third as much of the drug.
As leading organizations representing the Ambulatory Surgery Center (ASC) industry, we wish to address concerns raised in this month's issue of the Journal of the American Medical Association (JAMA) highlighting data from a 2008 Centers for Medicare and Medicaid Services (CMS) pilot study. The industry underscores its strong commitment to patient safety and its nationwide efforts to provide high-quality, patient-centered care at a low cost to the health care system.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Johanna Engel-brower, MD 30 E Hickman Rd, Waukee, IA 50263-5011 Ph: (515) 987-3447 | Johanna Engel-brower, MD 30 E Hickman Rd, Waukee, IA 50263-5011 Ph: (515) 987-3447 |
News Archive
A newly developed method for detecting glucose based on how it absorbs a specific type of light could spell the end of the painful, invasive finger-prick tests diabetics rely on to monitor their condition, says a Texas A&M University biomedical engineer who is developing the technology.
Lakewood-Amedex Inc., a leading developer of novel anti-infective pharmaceuticals, announced today that a recent series of in vitro studies conducted by Southern Research in Birmingham, Alabama, have demonstrated that its novel class of antimicrobials, named bisphosphocins, have proven effective at killing multidrug-resistant (MDR) strains of Mycobacterium tuberculosis, the bacteria responsible for the chronic lung infection tuberculosis.
Tumor-suppressor proteins work to inhibit tumor growth in our bodies and when they win, they spare us a battle with cancer. But one such protein, menin, appears to have a split personality.
Researchers have shown that a peptide (a chain of amino acids) called iRGD helps co-administered drugs penetrate deeply into tumor tissue. The peptide has been shown to substantially increase treatment efficacy against human breast, prostate and pancreatic cancers in mice, achieving the same therapeutic effect as a normal dose with one-third as much of the drug.
As leading organizations representing the Ambulatory Surgery Center (ASC) industry, we wish to address concerns raised in this month's issue of the Journal of the American Medical Association (JAMA) highlighting data from a 2008 Centers for Medicare and Medicaid Services (CMS) pilot study. The industry underscores its strong commitment to patient safety and its nationwide efforts to provide high-quality, patient-centered care at a low cost to the health care system.
› Verified 7 days ago
Dr. William H Schupp, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 842 Ne Alices Rd, Waukee, IA 50263 Phone: 515-875-9610 Fax: 515-875-9611 | |
Dr. William B Goble, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1025 Se Tallgrass Lane Ste 150, Waukee, IA 50263 Phone: 515-875-8070 Fax: 515-875-8071 | |
Brianne Nicole Day, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 25 W Hickman Road, Waukee, IA 50263 Phone: 515-643-7000 Fax: 515-643-7001 | |
Dr. Taylor Jo Johnson, DO Family Medicine Medicare: Medicare Enrolled Practice Location: 1025 Se Tallgrass Lane Ste 250, Waukee, IA 50263 Phone: 515-875-8300 Fax: 515-875-8201 | |
Dr. Christine Schaplowsky Davis, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 155 Bel Aire Dr, Waukee, IA 50263 Phone: 916-390-4195 | |
Imad F Francis, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1025 Se Tallgrass Lane Ste 150, Waukee, IA 50263 Phone: 515-875-8070 Fax: 515-875-8071 |